Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2010-02-05

Clinical Trial Update: Non-interventional Study -Observe Treatment Efficacy in Maintaining Symptoms Control in Schizophrenia With Seroquel XR

View source ↗

Summary

A completed non-interventional observational study evaluating the effectiveness of Seroquel XR (quetiapine extended-release) in maintaining symptom control in s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SEROQUEL XR (Quetiapine)

Snippet

Sponsor: AstraZeneca | Conditions: Schizophrenia | Status: COMPLETED